Global Cartilage Degeneration Market Size, Share And Growth Analysis For 2024-2033

The Business Research Company’s Cartilage Degeneration Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033

LONDON, GREATER LONDON, UK, July 19, 2024 /EINPresswire.com/ -- The cartilage degeneration market has experienced robust growth in recent years, expanding from $11.88 billion in 2023 to $12.63 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to aging population, joint injuries, obesity epidemic, sports injuries, limited self-repair capacity.

Strong Future Growth Anticipated
The cartilage degeneration market is projected to continue its strong growth, reaching $15.64 billion in 2028 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to regenerative medicine advancements, biologic injections, tissue engineering solutions, precision medicine, robotics-assisted surgery.

Explore Comprehensive Insights Into The Global Cartilage Degeneration Market With A Detailed Sample Report:
https://www.thebusinessresearchcompany.com/sample_request?id=13103&type=smp

Growth Driver Of The Cartilage Degeneration Market
The increasing prevalence of obesity is expected to propel the growth of the cartilage degeneration market going forward. Obesity is a medical condition characterized by an excessive accumulation of body fat to the extent that it may harm a person's health. Obesity can initiate and accelerate cartilage degeneration by increasing cartilage compressive forces and inflammatory cytokines. Obesity induces several pathological changes to the whole knee joint structure, including abnormal loading on the joint, joint malalignment, and muscle weakness.

Explore The Report Store To Make A Direct Purchase Of The Report:
https://www.thebusinessresearchcompany.com/report/cartilage-degeneration-global-market-report

Major Players And Market Trends
Key players in the cartilage degeneration market include Johnson & Johnson Services Inc., MEDIPOST Co. Ltd., Medtronic PLC, Stryker Corporation, Zimmer Biomet Holdings Inc., Smith and Nephew PLC.

Major companies operating in the cartilage degeneration market are developing innovative products, such as Agili-C, to support bone remodeling and cartilage regeneration. Agili-C is a cell-free, off-the-shelf implant used to repair cartilage and osteochondral defects in traumatic and osteoarthritic joints.

Segments:
1) By Procedure: Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell-Based Cartilage Resurfacing, Autologous Chondrocyte Implantation, Other Procedures
2) By Application: Knee, Hip, Other Applications
3) By End User: Hospitals And Specialty Clinics, Ambulatory Surgical Centers, Academic And Research Institutes

Geographical Insights: North America Leading The Market
North America was the largest region in the cartilage degeneration market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cartilage degeneration market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Cartilage Degeneration Market Definition
Cartilage degeneration refers to the gradual deterioration or breakdown of cartilage tissue, a smooth, flexible connective tissue covering the ends of bones in joints. Cartilage is a cushion that allows for smooth joint movement by reducing bone friction. Cartilage degeneration leads to pain, stiffness, and decreased joint function.

Cartilage Degeneration Global Market Report 2024 from The Business Research Company covers the following information:
• Market size data for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.
The Cartilage Degeneration Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on cartilage degeneration market size, cartilage degeneration market drivers and trends, cartilage degeneration market major players, cartilage degeneration competitors' revenues, cartilage degeneration market positioning, and cartilage degeneration market growth across geographies. The cartilage degeneration market report helps you gain in-depth insights into opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:
Major Orthopedic Joint Replacement Implants Global Market, Opportunities And Strategies To 2022
https://www.thebusinessresearchcompany.com/report/major-orthopedic-joint-replacement-implants-market

Craniomaxillofacial (CMF) Devices And Equipment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/craniomaxillofacial-cmf-devices-and-equipment-global-market-report

Joint Reconstruction Devices And Equipment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/joint-reconstruction-devices-and-equipment-global-market-report

About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn

Pioneering the Future of Cancer Care: Generic Oncology Drugs Market Insights